Harrow Health, Inc. 13D and 13G filings for Eton Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-04-30 07:00 am Sale |
2024-04-26 | 13D | Eton Pharmaceuticals, Inc. ETON |
HARROW INC. HROW |
0 0.000% |
-1,982,000 (Position Closed) |
Filing |
| 2022-01-28 4:05 pm Sale |
2021-04-12 | 13D | Eton Pharmaceuticals, Inc. ETON |
HARROW INC. HROW |
1,982,000 8.100% |
-1,518,000 (-43.37%) |
Filing |